{"id":47,"date":"2020-09-14T13:00:48","date_gmt":"2020-09-14T04:00:48","guid":{"rendered":"https:\/\/firm.or.jp\/en\/?page_id=47"},"modified":"2021-05-31T09:25:00","modified_gmt":"2021-05-31T00:25:00","slug":"history","status":"publish","type":"page","link":"https:\/\/firm.or.jp\/en\/about\/history\/","title":{"rendered":"Overview\u200b FIRM History\u200b"},"content":{"rendered":"\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
2011<\/td>\nJune<\/td>\nEstablished \u201cThe Forum for Innovative Regenerative Medicine (FIRM)\u201d with 14 companies<\/td>\n<\/tr>\n
2015<\/td>\nMarch<\/td>\nOpened the FIRM subsidiary office in Kansai area
\nEntered into Memorandum of Understanding (MOU) with The Alliance for Regenerative
\nMedicine (ARM) in the US<\/td>\n<\/tr>\n
2016<\/td>\nMay<\/td>\nEntered into MOU with Centre for Commercialization of Regenerative Medicine (CCRM) in Canada
\nfor accelerating Regenerative Medicine<\/td>\n<\/tr>\n
<\/td>\nJuly<\/td>\nHosted the 1st \u201cRegenerative Medicine Crossroad in Tokyo\u201d<\/td>\n<\/tr>\n
<\/td>\nOctober<\/td>\nEntered into MOU with The Council for Advanced Regenerative Medicine (CARM) in Korea for
\naccelerating Regenerative Medicine in both countries
\nIntroduced the environments surrounding Regenerative Medicine in Japan at the workshop in
\nCell & Gene Meeting on the MESA 2016
\nHosted the 2nd “Regenerative Medicine Crossroad in Tokyo\u201d
\nCosponsored \u201cRegenerative Medicine Japan\u201d session in BioJapan 2016 with Japan
\nBioindustry Association (JBA) and conducted four sponsored seminars
\nCosponsored the 1st \u201cIndustry-Academia-Government Regenerative Medicine Symposium<\/td>\n<\/tr>\n
<\/td>\nNovember<\/td>\nCosponsored the \u201c2016 World Alliance Forum in San Francisco\u201d
\nEntered into MOU with China Medical Biotech Association (CMBA) in China
\nHosted the 1st \u201cRegenerative medicine venture supporting seminar\u201d<\/td>\n<\/tr>\n
<\/td>\nDecember<\/td>\nReceived approval of ISO New Work Item Proposal on design process to establish
\nspecification of cell transportation<\/td>\n<\/tr>\n
2017<\/td>\nFebruary<\/td>\nHosted the 3rd \u201cRegenerative Medicine Crossroad in Tokyo\u201d
\nHosted the 2nd \u201cRegenerative medicine venture supporting seminar\u201d<\/td>\n<\/tr>\n
<\/td>\nAugust<\/td>\nEntered into MOU with Association of Biotechnology Led Enterprises (ABLE) in India<\/td>\n<\/tr>\n
<\/td>\nOctober<\/td>\nEntered into MOU with AusBiotech in Australia
\nCosponsored \u201cAustralia – Japan Regenerative Medicine Round Table\u201d
\nEntered into MOU with Cell and Gene Therapy Catapult (CGT Catapult) in UK
\nEntered into MOU with International Society for Cell & Gene Therapy (ISCT)<\/td>\n<\/tr>\n
2018<\/td>\nFebruary<\/td>\nEntered into MOU with Israel Stem Cell Society (ISCS) in Israel<\/td>\n<\/tr>\n
<\/td>\nApril<\/td>\nHosted \u201cThe 1st Asia Partnership Conference of Regenerative Medicine Associations (APACRM)\u201d
\nEntered into MOU with Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) in Taiwan<\/td>\n<\/tr>\n
<\/td>\nSeptember<\/td>\nHosted the 8th \u201cRegenerative Medicine Crossroad in Tokyo\u201d
\nHosted the 6th \u201cRegenerative medicine venture supporting seminar\u201d<\/td>\n<\/tr>\n
<\/td>\nOctober<\/td>\nHosted 2018 APACRM \u2013 Working Level Meeting (WLM) in Yokohama.
\nThe chairperson of FIRM Standardization Committee was elected as a director of Standards Coordinating Body, US.\n<\/td>\n<\/tr>\n
<\/td>\nDecember<\/td>\nIssued Material Standard (ISO\/TS 20399 series) which is ISO standard.
\nReleased the second edition of FIRM guidelines on the points to note when selecting plastic equipment which are used in the process of cell processing such as regenerative medicine and preservation and storage of cells.
\nWorked together with the Japanese Society for Regenerative Medicine to build FIRM education system whose name was \u201cClinical embryologist training system. \u201c
\nIssued International Standard (Technical Specification) on request for Ancillary materials for manufacturing regenerative medicine products from ISO.\n<\/td>\n<\/tr>\n
2019<\/td>\nMarch<\/td>\nHosted symposium \u201cInternational Standardization by unification of industry, government, academia and people: Impact on Regenerative Medicine\u201d at the 18th General Meeting of the Japanese Society for Regenerative Medicine.<\/td>\n<\/tr>\n
<\/td>\nApril<\/td>\nHosted the second APACRM at Nihonbashi.
\nOfficially launched FIRM educational system, \u201cClinical embryologist training system. \u201c
\nEntrusted International Standardization Project of on cell evaluation and applications to product manufacturing by METI and MRI.\n<\/td>\n<\/tr>\n
<\/td>\nJune<\/td>\nHosted the 7th General Meeting and Joint Working Group Meeting of ISO\/TC276 at Life Science Hub Nihonbashi.<\/td>\n<\/tr>\n
<\/td>\nJuly<\/td>\nHosted ISO\/TC276 information session at Nihonbashi Life Science Building.<\/td>\n<\/tr>\n
<\/td>\nAugust<\/td>\nReleased \u201cGuidance on applications for approval and renewal of product and specified cell-processing products based on the Pharmaceutical and Regenerative Medicine Law: for domestic and foreign companies and medical institutions involved in regenerative medicine\u201d from Seibundo Shinkosha, which was the firstly published book from FIRM.
\nHosted the 8th gathering of Start-up supporting forum. The 9th forum in December 2019, the 10th forum in February 2020.\n<\/td>\n<\/tr>\n
<\/td>\nSeptember<\/td>\nHosted the 10th meeting of Regenerative Medicine Crossroad. Hosted the 11th, in February 2020.<\/td>\n<\/tr>\n
<\/td>\nOctober<\/td>\nHosted 2019 APACRM liaison meeting of practical business (APACRM- WLM) in Yokohama.
\nHosted Japan Session at Cell & Gene Meeting on the MESA 2019.
\nSupporting Industries Committee planed FIRM booth exhibit in Regenerative Medicine Japan, and actively explained activities of each committee, each WG and member companies.\n<\/td>\n<\/tr>\n
2020<\/td>\nApril<\/td>\nEntrusted International Standardization Project for industrialization of cell applied regenerative medicines and their technology by METI and MRI.<\/td>\n<\/tr>\n
<\/td>\nJune<\/td>\nReleased \u201cChecklist on items from development to approval of Regenerative Medicine products \u201conly to the FIRM members.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\nIn addition to the above, FIRM has made a number of proposals and public comments, hosted roundtable discussions and seminars with government offices and affiliates, and through these activities, FIRM is strengthening the cooperation between Regenerative Medicine organizations both in and out of Japan.
\n(As of July, 2020.)<\/p>\n","protected":false},"excerpt":{"rendered":"

2011 June Established \u201cThe Forum for Innovative Regenerative Medicine (FIRM)\u201d with 14 companies 2015 March Ope […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":40,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-47","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/pages\/47","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/comments?post=47"}],"version-history":[{"count":6,"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/pages\/47\/revisions"}],"predecessor-version":[{"id":662,"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/pages\/47\/revisions\/662"}],"up":[{"embeddable":true,"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/pages\/40"}],"wp:attachment":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/media?parent=47"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}